| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|
Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q4 2024 | 14 | $1.21B | +$303M | -$195M | +$108M | GIL, UTI, SONO, GMS, HRI | 13F-HR | 2/14/2025, 04:16 PM |
| Q3 2024 | 14 | $1.03B | +$183M | -$335M | -$152M | GIL, UTI, SONO, GMS, HRI | 13F-HR | 11/14/2024, 04:20 PM |
| Q2 2024 | 14 | $1.12B | +$128M | -$31.8K | +$128M | GIL, UTI, RCM, MODV, GMS | 13F-HR | 8/14/2024, 04:15 PM |
| Q1 2024 | 11 | $1.08B | +$70.2M | -$342M | -$272M | GIL, UTI, RCM, PRPL, SONO | 13F-HR | 5/15/2024, 04:05 PM |
| Q4 2023 | 11 | $1.25B | +$233M | -$106M | +$127M | GIL, GMS, UTI, MODV, SONO | 13F-HR | 2/14/2024, 04:26 PM |
| Q3 2023 | 11 | $959M | +$127M | -$82.2M | +$44.7M | GIL, GMS, MODV, SONO, PRPL | 13F-HR | 11/14/2023, 04:22 PM |
| Q2 2023 | 12 | $1.11B | +$126M | -$338M | -$212M | GIL, GMS, PRPL, SONO, MODV | 13F-HR | 8/14/2023, 04:51 PM |
| Q1 2023 | 12 | $1.32B | +$171M | -$262M | -$90.7M | GMS, GIL, SONO, PRPL, MODV | 13F-HR | 5/15/2023, 04:58 PM |
| Q4 2022 | 13 | $1.34B | +$128M | -$180M | -$51.6M | GMS, BLDR, PRPL, GIL, MODV | 13F-HR | 2/14/2023, 04:15 PM |
| Q3 2022 | 13 | $1.23B | +$127M | -$78.2M | +$49.1M | BLDR, GMS, PRPL, MODV, SONO | 13F-HR | 11/14/2022, 04:57 PM |
| Q2 2022 | 14 | $1.13B | +$156M | -$2.8M | +$153M | BLDR, GMS, PRPL, MODV, SONO | 13F-HR | 8/15/2022, 05:39 PM |
| Q1 2022 | 13 | $1.33B | +$337M | -$7.55M | +$330M | BLDR, GMS, PRPL, MODV, SONO | 13F-HR | 5/16/2022, 04:13 PM |
| Q4 2021 | 11 | $1.31B | +$269M | -$370M | -$100M | BLDR, GMS, PRPL, MODV, BLBD | 13F-HR | 2/14/2022, 04:15 PM |
| Q3 2021 | 8 | $1.13B | +$16.9M | -$47.2M | -$30.3M | BLDR, MODV, GMS, PRPL, GORV | 13F-HR | 11/16/2021, 09:52 AM |
| Q2 2021 | 7 | $1.13B | +$34.9M | -$200M | -$165M | BLDR, MODV, GMS, PRPL, GORV | 13F-HR | 8/16/2021, 04:41 PM |
| Q1 2021 | 7 | $1.34B | +$711M | -$631M | +$80.1M | PRPL, BLDR, MODV, GMS, GORV | 13F-HR | 5/17/2021, 04:15 PM |
| Q4 2020 | 10 | $1.22B | +$176M | -$144M | +$32.5M | PRPL, BMCH, PRSC, GMS, FBM | 13F-HR | 2/16/2021, 04:30 PM |
| Q3 2020 | 11 | $916M | +$46.7M | -$37.2M | +$9.48M | BMCH, PRPL, PRSC, GIL, GMS | 13F-HR | 11/16/2020, 04:15 PM |
| Q2 2020 | 13 | $686M | +$208M | -$106M | +$102M | PRPL, BMCH, PRSC, GIL, GMS | 13F-HR | 8/14/2020, 04:12 PM |
| Q1 2020 | 18 | $369M | +$127M | -$14.3M | +$112M | BMCH, PRSC, PRPL, LGC, CNR | 13F-HR | 5/15/2020, 04:00 PM |
| Q4 2019 | 11 | $376M | +$76.7M | -$62.2M | +$14.5M | BMCH, PRPL, PRSC, CNR, LGC | 13F-HR | 2/14/2020, 04:35 PM |
| Q3 2019 | 14 | $362M | +$63.9M | -$44.1M | +$19.8M | BMCH, PRSC, PRPL, BXC, CNR | Restatement | 2/14/2020, 04:10 PM |
| Q2 2019 | 13 | $309M | +$30.7M | -$4.13M | +$26.6M | PRSC, BMCH, PRPL, LGCU, RLH | 13F-HR | 8/14/2019, 04:28 PM |
| Q1 2019 | 13 | $277M | +$15.3M | -$4.13M | +$11.2M | PRSC, BMCH, LGCU, RLH, PRPL | 13F-HR | 5/15/2019, 04:30 PM |
| Q4 2018 | 13 | $268M | +$57.6M | -$7.04M | +$50.6M | PRSC, PRPL, BMCH, LGCU, RLH | 13F-HR | 2/14/2019, 04:16 PM |
| Q3 2018 | 9 | $246M | +$18.7M | -$5.46M | +$13.2M | PRSC, RLH, PRPL, LGCU, BKD | 13F-HR | 11/13/2018, 05:48 PM |
| Q2 2018 | 9 | $259M | +$47.2M | -$57.4M | -$10.2M | PRSC, PRPL, RLH, LGCU, BKD | 13F-HR | 8/14/2018, 04:53 PM |
| Q1 2018 | 10 | $249M | +$73.7M | -$808K | +$72.9M | PRSC, PRPL, LGCU, LHCG, UTI | 13F-HR | 5/15/2018, 05:03 PM |
| Q4 2017 | 8 | $157M | +$38.5M | -$21.5M | +$17M | PRSC, LGCU, UTI, ARQ, LHCG | 13F-HR | 2/14/2018, 05:18 PM |
| Q3 2017 | 5 | $135M | $0 | -$37.5M | -$37.5M | PRSC, UTI, ARQ, BIOS, DXLG | 13F-HR | 11/14/2017, 03:47 PM |
| Q2 2017 | 8 | $164M | $0 | -$74.2M | -$74.2M | PRSC, BIOS, UTI, BLBD, LHCG | 13F-HR | 8/14/2017, 03:22 PM |
| Q1 2017 | 10 | $222M | +$10.3M | -$28.4M | -$18.1M | PRSC, LHCG, ASNA, ARQ, BLBD | 13F-HR | 5/15/2017, 04:56 PM |
| Q4 2016 | 7 | $222M | $0 | -$53.6M | -$53.6M | PRSC, BLBD, LHCG, ASNA, ARQ | 13F-HR | 2/14/2017, 05:34 PM |
| Q3 2016 | 10 | $285M | +$30.4M | -$392K | +$30.1M | PRSC, BLBD, LHCG, ASNA, ACW | 13F-HR | 11/14/2016, 05:30 PM |
| Q2 2016 | 9 | $240M | +$22.5M | -$13M | +$9.52M | PRSC, LHCG, ASNA, BLBD, BIOS | 13F-HR | 8/15/2016, 05:05 PM |
| Q1 2016 | 11 | $258M | +$26M | -$16.8M | +$9.17M | PRSC, ASNA, LHCG, BLBD, UTI | 13F-HR | 5/16/2016, 04:17 PM |
| Q4 2015 | 11 | $246M | +$25.8M | -$17.1M | +$8.61M | PRSC, LHCG, BLBD, ASNA, UTI | 13F-HR | 2/16/2016, 05:09 PM |
| Q3 2015 | 8 | $248M | +$6M | -$41.3M | -$35.3M | PRSC, LHCG, ASNA, BLBD, ACW | 13F-HR | 11/16/2015, 04:06 PM |
| Q2 2015 | 8 | $295M | +$9.1M | -$53.9M | -$44.8M | PRSC, LHCG, ASNA, BLBD, ACW | 13F-HR | 8/14/2015, 04:28 PM |
| Q1 2015 | 8 | $332M | +$35.6M | -$57M | -$21.4M | PRSC, LHCG, CROX, ACW, ASNA | 13F-HR | 5/15/2015, 01:24 PM |
| Q4 2014 | 9 | $311M | +$36.2M | -$2.8M | +$33.4M | PRSC, LHCG, ARQ, CROX, ACW | 13F-HR | 2/17/2015, 08:40 PM |
| Q3 2014 | 8 | $280M | +$16.9M | -$49.1M | -$32.3M | PRSC, LHCG, CROX, ARQ, ACW | 13F-HR | 11/14/2014, 11:42 AM |
| Q2 2014 | 10 | $298M | +$26.6M | -$7.65M | +$18.9M | PRSC, LHCG, ACW, CROX, ARQ | 13F-HR | 8/14/2014, 04:39 PM |
| Q1 2014 | 12 | $259M | +$48.9M | -$22.3M | +$26.6M | PRSC, LHCG, ACW, CROX, MED | 13F-HR | 5/15/2014, 04:20 PM |
| Q4 2013 | 11 | $236M | $0 | $0 | LHCG, PRSC, CROX, ACW, JMBA | 13F-HR | 2/14/2014, 04:00 PM |